Evidence map›Paper›PMID 28473322›Full record

ArticleAmerican journal of physiology. Lung cellular and molecular physiology2017

Therapeutic blockade of CD54 attenuates pulmonary barrier damage in T cell-induced acute lung injury.

Julia Svedova, Antoine Ménoret, Payal Mittal, Joseph M Ryan, James A Buturla, Anthony T Vella

Open access · bronzeAbstract read
In one paragraph

Article in American journal of physiology. Lung cellular and molecular physiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. IFN-American journal of respiratory cell and molecular biology · 2023
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Julia SvedovaDepartment of Immunology, School of Medicine, UConn Health, Farmington, Connecticut.
Antoine MénoretDepartment of Immunology, School of Medicine, UConn Health, Farmington, Connecticut.
Payal MittalDepartment of Immunology, School of Medicine, UConn Health, Farmington, Connecticut.
Joseph M RyanDepartment of Immunology, School of Medicine, UConn Health, Farmington, Connecticut.
James A ButurlaDepartment of Internal Medicine, UConn Health, Farmington, Connecticut.
Anthony T VellaDepartment of Immunology, School of Medicine, UConn Health, Farmington, Connecticut; vella@uchc.edu.
UConn Health · USUniversity of Connecticut · US

Funding

Sustained adaptive immunity in the mucosaP01AI056172 · NIAID · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI VELLA, ANTHONY T · 2003 to 2017
$22.3M
NIAID NIH HHS P01 AI056172
6 · The paper itself

Abstract

Acute respiratory distress syndrome (ARDS) is a serious, often fatal condition without available pharmacotherapy. Although the role of innate cells in ARDS has been studied extensively, emerging evidence suggests that T cells may be involved in disease etiology.

Indexed as

Acute Lung InjuryAdministration, InhalationAnimalsApoptosisBiomarkersBronchoalveolar Lavage FluidCell CountChemokinesEndothelial CellsEnterotoxinsFemaleInflammationIntercellular Adhesion Molecule-1LungLymphocyte ActivationMaleBiomarkersChemokinesenterotoxin A, StaphylococcalEnterotoxinsIntercellular Adhesion Molecule-1acute lung injuryCD54endothelial cellsStaphylococcus aureus enterotoxinT cells

Identifiers

PMID28473322
PMCPMC6148083
OpenAlexW2610202553

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.